Thu Hien Nguyen1,2, Ngoc-Lan Nguyen1, Chi Dung Vu3, Can Thi Bich Ngoc1, Ngoc Khanh Nguyen3, Huy Hoang Nguyen4,5. 1. Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, 100000, Vietnam. 2. Graduate University of Sciences and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, 100000, Vietnam. 3. Department of Medical Genetics, Metabolism and Endocrinology, Vietnam National Children's Hospital, 18/879 La Thanh, Dong Da, Hanoi, 100000, Vietnam. 4. Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, 100000, Vietnam. nhhoang@igr.ac.vn. 5. Graduate University of Sciences and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, 100000, Vietnam. nhhoang@igr.ac.vn.
Abstract
BACKGROUND: Primordial dwarfism (PD) is a group of genetically heterogeneous disorders related to developmental disabilities occurring in the uterus and prolongs during all stages of life, resulting in short stature, facial deformities and abnormal brain. OBJECTIVE: To determine the exact cause of the disease in two Vietnamese patients priory diagnosed with PD by severe pre-and postnatal growth retardation with marked microcephaly and some bone abnormalities. METHODS: Whole-exome sequencing was performed for the two patients and mutations in genes related to PD were screened. Sanger sequencing was applied to examine the mutations in the patients of their families. RESULTS: Three novel mutations in the PCNT gene which have not been reported previously were identified in the two patients. Of which, two frameshift mutations (p.Thr479Profs*6 and p.Glu2742Alafs*8) were detected in patient I and one stop-gained mutation (p.Gln1907*) was detected in the patient II. These mutations may result in a truncated PCNT protein, leading to an inactivated PACT domain corresponding to residue His3138-Trp3216 of PCNT protein. Therefore, the three mutations may cause a deficiency of protein functional activity and result in the phenotypes of primordial dwarfism in the two patients. CONCLUSIONS: Clinical presentations in combination with genetic analyses supported an accurate diagnosis of the two patients with microcephalic osteodysplastic primordial dwarfism type II (MOPD II). In addition, these results have important implications for prenatal genetic screening and genetic counseling for the families.
BACKGROUND: Primordial dwarfism (PD) is a group of genetically heterogeneous disorders related to developmental disabilities occurring in the uterus and prolongs during all stages of life, resulting in short stature, facial deformities and abnormal brain. OBJECTIVE: To determine the exact cause of the disease in two Vietnamese patients priory diagnosed with PD by severe pre-and postnatal growth retardation with marked microcephaly and some bone abnormalities. METHODS: Whole-exome sequencing was performed for the two patients and mutations in genes related to PD were screened. Sanger sequencing was applied to examine the mutations in the patients of their families. RESULTS: Three novel mutations in the PCNT gene which have not been reported previously were identified in the two patients. Of which, two frameshift mutations (p.Thr479Profs*6 and p.Glu2742Alafs*8) were detected in patient I and one stop-gained mutation (p.Gln1907*) was detected in the patient II. These mutations may result in a truncated PCNT protein, leading to an inactivated PACT domain corresponding to residue His3138-Trp3216 of PCNT protein. Therefore, the three mutations may cause a deficiency of protein functional activity and result in the phenotypes of primordial dwarfism in the two patients. CONCLUSIONS: Clinical presentations in combination with genetic analyses supported an accurate diagnosis of the two patients with microcephalic osteodysplastic primordial dwarfism type II (MOPD II). In addition, these results have important implications for prenatal genetic screening and genetic counseling for the families.
Authors: Michael B Bober; Tim Niiler; Angela L Duker; Jennie E Murray; Tara Ketterer; Margaret E Harley; Sabah Alvi; Christina Flora; Cecilie Rustad; Ernie M H F Bongers; Louise S Bicknell; Carol Wise; Andrew P Jackson Journal: Am J Med Genet A Date: 2012-07-20 Impact factor: 2.802
Authors: Ghada M H Abdel-Salam; Inas S M Sayed; Hanan H Afifi; Sherif F Abdel-Ghafar; Maha R Abouzaid; Samira I Ismail; Mona S Aglan; Mahmoud Y Issa; Hala T El-Bassyouni; Ghada El-Kamah; Laila K Effat; Maha Eid; Maha S Zaki; Samia A Temtamy; Mohamed S Abdel-Hamid Journal: Am J Med Genet A Date: 2020-04-08 Impact factor: 2.802
Authors: Judith G Hall; Christina Flora; Charles I Scott; Richard M Pauli; Kimi I Tanaka Journal: Am J Med Genet A Date: 2004-09-15 Impact factor: 2.802
Authors: Elen Griffith; Sarah Walker; Carol-Anne Martin; Paola Vagnarelli; Tom Stiff; Bertrand Vernay; Nouriya Al Sanna; Anand Saggar; Ben Hamel; William C Earnshaw; Penny A Jeggo; Andrew P Jackson; Mark O'Driscoll Journal: Nat Genet Date: 2007-12-23 Impact factor: 38.330